|
|
||||||||
The FASEB Journal, Vol 10, 1183-1191, Copyright © 1996 by The Federation of American Societies for Experimental Biology
REVIEWS |
DD Roberts
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Thrombospondin-1 (TSP1) is an extracellular matrix glycoprotein that influences cell adhesion, motility, and growth. Based on its effects on tumor and endothelial cell behavior, this member of the thrombospondin gene family has attracted interest as a potential regulator of tumor growth and metastasis. Initial studies have confirmed that increased TSP1 expression suppresses growth or metastasis of some tumors in vivo and inhibits angiogenesis. These activities are cell type specific, however, since overexpression of TSP1 in some tumors causes increased tumor progression. One basis for these apparently conflicting observations may be the complexity of the protein. TSP1 interacts specifically with several cell-surface receptors, heparan sulfate proteoglycans, growth factors, and other matrix components. These multiple binding specificities, combined with the ability of TSP1 to activate latent transforming growth factor beta and inhibit several proteases, suggest that exposure to TSP1 may initiate several intracellular signals. The integration of these signals may allow varied responses to TSP1. Furthermore, these signals may be received by the tumor cells, endothelial cells responsible for neovascularization, stromal cells, or cells of the host immune system. TSP1 influences specific behaviors of each cell type. Relating these phenomena to the molecular interactions of TSP1 observed in vitro may lead to novel therapeutic strategies for controlling cancer progression and metastasis.-Roberts, D. D. Regulation of tumor growth and metastasis by thrombospondin-1.
This article has been cited by other articles:
![]() |
S. Heximer and M. Husain A Candidate Hypertension Gene: Will SPON1 Hold Salt and Water? Circ. Res., April 13, 2007; 100(7): 940 - 942. [Full Text] [PDF] |
||||
![]() |
D. D. Roberts, J. S. Isenberg, L. A. Ridnour, and D. A. Wink Nitric Oxide and Its Gatekeeper Thrombospondin-1 in Tumor Angiogenesis Clin. Cancer Res., February 1, 2007; 13(3): 795 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rennebeck, M. Martelli, and N. Kyprianou Anoikis and Survival Connections in the Tumor Microenvironment: Is There a Role in Prostate Cancer Metastasis? Cancer Res., December 15, 2005; 65(24): 11230 - 11235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Sutton, K. O'Byrne, J. C. Goddard, L.-J. Marshall, L. Jones, G. Garcea, A. R. Dennison, G. Poston, D. M. Lloyd, and D. P. Berry Expression of Thrombospondin-1 in Resected Colorectal Liver Metastases Predicts Poor Prognosis Clin. Cancer Res., September 15, 2005; 11(18): 6567 - 6573. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Ridnour, J. S. Isenberg, M. G. Espey, D. D. Thomas, D. D. Roberts, and D. A. Wink Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1 PNAS, September 13, 2005; 102(37): 13147 - 13152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kuznetsova, A. J. Day, D. J. Mahoney, M. S. Rugg, D. F. Mosher, and D. D. Roberts The N-terminal Module of Thrombospondin-1 Interacts with the Link Domain of TSG-6 and Enhances Its Covalent Association with the Heavy Chains of Inter-{alpha}-trypsin Inhibitor J. Biol. Chem., September 2, 2005; 280(35): 30899 - 30908. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saumet, M. B. Slimane, M. Lanotte, J. Lawler, and V. Dubernard Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/{alpha}v{beta}3 in promyelocytic leukemia NB4 cells Blood, July 15, 2005; 106(2): 658 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. McLaughlin, M. R. Mazzoni, J. H. Cleator, L. Earls, A. L. Perdigoto, J. D. Brooks, J. A. S. Muldowney III, D. E. Vaughan, and H. E. Hamm Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells J. Biol. Chem., June 10, 2005; 280(23): 22172 - 22180. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Weigelt, A. M. Glas, L. F. A. Wessels, A. T. Witteveen, J. L. Peterse, and L. J. van't Veer Gene expression profiles of primary breast tumors maintained in distant metastases PNAS, December 23, 2003; 100(26): 15901 - 15905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Calzada, J. M. Sipes, H. C. Krutzsch, P. D. Yurchenco, D. S. Annis, D. F. Mosher, and D. D. Roberts Recognition of the N-terminal Modules of Thrombospondin-1 and Thrombospondin-2 by {alpha}6{beta}1 Integrin J. Biol. Chem., October 17, 2003; 278(42): 40679 - 40687. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-W. Yang, S. Liu, Y. Tian, H. R. Salwen, A. Chlenski, J. Weinstein, and S. L. Cohn Methylation-associated Silencing of the Thrombospondin-1 Gene in Human Neuroblastoma Cancer Res., October 1, 2003; 63(19): 6299 - 6310. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyata, S. Koga, K. Takehara, H. Kanetake, and S. Kanda Expression of Thrombospondin-derived 4N1K Peptide-containing Proteins in Renal Cell Carcinoma Tissues Is Associated with a Decrease in Tumor Growth and Angiogenesis Clin. Cancer Res., May 1, 2003; 9(5): 1734 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Petrik, P. A. Gentry, J.-J. Feige, and J. LaMarre Expression and Localization of Thrombospondin-1 and -2 and Their Cell-Surface Receptor, CD36, During Rat Follicular Development and Formation of the Corpus Luteum Biol Reprod, November 1, 2002; 67(5): 1522 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Valenzuela, I. M. B. Francischetti, V. M. Pham, M. K. Garfield, T. N. Mather, and J. M. C. Ribeiro Exploring the sialome of the tick Ixodes scapularis J. Exp. Biol., September 15, 2002; 205(18): 2843 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nash, M. T. Deavers, and R. S. Freedman The Expression of Decorin in Human Ovarian Tumors Clin. Cancer Res., June 1, 2002; 8(6): 1754 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, H. Sonoo, J. Kurebayashi, T. Nomura, S. Ohkubo, Y. Yamamoto, and S. Yamamoto Inhibition of Infiltration and Angiogenesis by Thrombospondin-1 in Papillary Thyroid Carcinoma Clin. Cancer Res., May 1, 2002; 8(5): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. J. Calzada, J. M. Sipes, J. A. Cashel, H. C. Krutzsch, D. S. Annis, D. F. Mosher, and D. D. Roberts Interactions of thrombospondins with {alpha}4{beta}1 integrin and CD47 differentially modulate T cell behavior J. Cell Biol., April 29, 2002; 157(3): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuno, C. Baba, A. Asaka, C. Matsushima, K. Matsushima, and R. Hosono The Caenorhabditis elegans ADAMTS Family Gene adt-1 Is Necessary for Morphogenesis of the Male Copulatory Organs J. Biol. Chem., March 29, 2002; 277(14): 12228 - 12236. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cacciotti, L. Strizzi, G. Vianale, L. Iaccheri, R. Libener, C. Porta, M. Tognon, G. Gaudino, and L. Mutti The Presence of Simian-Virus 40 Sequences in Mesothelioma and Mesothelial Cells Is Associated with High Levels of Vascular Endothelial Growth Factor Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 189 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazzucchelli Protein S100A4: Too Long Overlooked by Pathologists? Am. J. Pathol., January 1, 2002; 160(1): 7 - 13. [Full Text] [PDF] |
||||
![]() |
F. McLaughlin, V. J. Ludbrook, J. Cox, I. von Carlowitz, S. Brown, and A. M. Randi Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation Blood, December 1, 2001; 98(12): 3332 - 3339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lawler, W.-M. Miao, M. Duquette, N. Bouck, R. T. Bronson, and R. O. Hynes Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice Am. J. Pathol., November 1, 2001; 159(5): 1949 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sargiannidou, J. Zhou, and G. P. Tuszynski The Role of Thrombospondin-1 in Tumor Progression Experimental Biology and Medicine, September 1, 2001; 226(8): 726 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Straume and L. A. Akslen Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas Am. J. Pathol., July 1, 2001; 159(1): 223 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hoon Kang, Y.-H. Shim, H.-Y. Jung, W. Ho Kim, J. Y. Ro, and M.-G. Rhyu CpG Island Methylation in Premalignant Stages of Gastric Carcinoma Cancer Res., April 1, 2001; 61(7): 2847 - 2851. [Abstract] [Full Text] |
||||
![]() |
Z. Li, L. He, K. E. Wilson, and D. D. Roberts Thrombospondin-1 Inhibits TCR-Mediated T Lymphocyte Early Activation J. Immunol., February 15, 2001; 166(4): 2427 - 2436. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Claudio, P. Stiegler, C. M. Howard, C. Bellan, C. Minimo, G. M. Tosi, J. Rak, A. Kovatich, Paola De Fazio, P. Micheli, et al. RB2/p130 Gene-enhanced Expression Down-Regulates Vascular Endothelial Growth Factor Expression and Inhibits Angiogenesis in Vivo Cancer Res., January 1, 2001; 61(2): 462 - 468. [Abstract] [Full Text] |
||||
![]() |
F. Bertucci, R. Houlgatte, A. Benziane, S. Granjeaud, J. Adelaide, R. Tagett, B. Loriod, J. Jacquemier, P. Viens, B. Jordan, et al. Gene expression profiling of primary breast carcinomas using arrays of candidate genes Hum. Mol. Genet., December 1, 2000; 9(20): 2981 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chandrasekaran, C.-Z. He, H. Al-Barazi, H. C. Krutzsch, M. L. Iruela-Arispe, and D. D. Roberts Cell Contact-dependent Activation of alpha 3beta 1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1 Mol. Biol. Cell, September 1, 2000; 11(9): 2885 - 2900. [Abstract] [Full Text] |
||||
![]() |
A. Shafiee, J. S. Penn, H. C. Krutzsch, J. K. Inman, D. D. Roberts, and D. A. Blake Inhibition of Retinal Angiogenesis by Peptides Derived from Thrombospondin-1 Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2378 - 2388. [Abstract] [Full Text] |
||||
![]() |
K. R. Laderoute, R. M. Alarcon, M. D. Brody, J. M. Calaoagan, E. Y. Chen, A. M. Knapp, Z. Yun, N. C. Denko, and A. J. Giaccia Opposing Effects of Hypoxia on Expression of the Angiogenic Inhibitor Thrombospondin 1 and the Angiogenic Inducer Vascular Endothelial Growth Factor Clin. Cancer Res., July 1, 2000; 6(7): 2941 - 2950. [Abstract] [Full Text] |
||||
![]() |
M. Tenan, G. Fulci, M. Albertoni, A.-C. Diserens, M.-F. Hamou, M. El Atifi-Borel, J.-J. Feige, M. S. Pepper, and E. G. Van Meir Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells J. Exp. Med., May 15, 2000; 191(10): 1789 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Feitsma, H. Hausser, H. Robenek, H. Kresse, and P. Vischer Interaction of Thrombospondin-1 and Heparan Sulfate from Endothelial Cells. STRUCTURAL REQUIREMENTS OF HEPARAN SULFATE J. Biol. Chem., March 24, 2000; 275(13): 9396 - 9402. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. MiyajimaUchida, H. Hayashi, R. Beppu, M. Kuroki, M. Fukami, F. Arakawa, Y. Tomita, M. Kuroki, and K. Oshima Production and Accumulation of Thrombospondin-1 in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 561 - 567. [Abstract] [Full Text] |
||||
![]() |
W. S. Park, J. Y. Park, R. R. Oh, N. J. Yoo, S. H. Lee, M. S. Shin, H. K. Lee, S. Han, S. K. Yoon, S. Y. Kim, et al. A Distinct Tumor Suppressor Gene Locus on Chromosome 15q21.1 in Sporadic Form of Colorectal Cancer Cancer Res., January 1, 2000; 60(1): 70 - 73. [Abstract] [Full Text] |
||||
![]() |
N.-h. Guo, N. S. Templeton, H. Al-Barazi, J. Cashel, J. M. Sipes, H. C. Krutzsch, and D. D. Roberts Thrombospondin-1 Promotes {{alpha}}3{beta}1 Integrin-mediated Adhesion and Neurite-like Outgrowth and Inhibits Proliferation of Small Cell Lung Carcinoma Cells Cancer Res., January 1, 2000; 60(2): 457 - 466. [Abstract] [Full Text] |
||||
![]() |
G. Bunone, P. Vigneri, L. Mariani, S. Buto, P. Collini, S. Pilotti, M. A. Pierotti, and I. Bongarzone Expression of Angiogenesis Stimulators and Inhibitors in Human Thyroid Tumors and Correlation with Clinical Pathological Features Am. J. Pathol., December 1, 1999; 155(6): 1967 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Wilson, Z. Li, M. Kara, K. L. Gardner, and D. D. Roberts {beta}1 Integrin- and Proteoglycan-Mediated Stimulation of T Lymphoma Cell Adhesion and Mitogen-Activated Protein Kinase Signaling by Thrombospondin-1 and Thrombospondin-1 Peptides J. Immunol., October 1, 1999; 163(7): 3621 - 3628. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Pike, L. Yao, J. Setsuda, K. D. Jones, B. Cherney, E. Appella, K. Sakaguchi, H. Nakhasi, C. D. Atreya, J. Teruya-Feldstein, et al. Calreticulin and Calreticulin Fragments Are Endothelial Cell Inhibitors That Suppress Tumor Growth Blood, October 1, 1999; 94(7): 2461 - 2468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Sipes, H. C. Krutzsch, J. Lawler, and D. D. Roberts Cooperation between Thrombospondin-1 Type 1 Repeat Peptides and alpha vbeta 3 Integrin Ligands to Promote Melanoma Cell Spreading and Focal Adhesion Kinase Phosphorylation J. Biol. Chem., August 6, 1999; 274(32): 22755 - 22762. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cinatl Jr., R. Kotchetkov, M. Scholz, J. Cinatl, J.-U. Vogel, P. H. Driever, and H. W. Doerr Human Cytomegalovirus Infection Decreases Expression of Thrombospondin-1 Independent of the Tumor Suppressor Protein p53 Am. J. Pathol., July 1, 1999; 155(1): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Goldblum, B. A. Young, P. Wang, and J. E. Murphy-Ullrich Thrombospondin-1 Induces Tyrosine Phosphorylation of Adherens Junction Proteins and Regulates an Endothelial Paracellular Pathway Mol. Biol. Cell, May 1, 1999; 10(5): 1537 - 1551. [Abstract] [Full Text] |
||||
![]() |
S. Chandrasekaran, N.-h. Guo, R. G. Rodrigues, J. Kaiser, and D. D. Roberts Pro-adhesive and Chemotactic Activities of Thrombospondin-1 for Breast Carcinoma Cells Are Mediated by alpha 3beta 1 Integrin and Regulated by Insulin-like Growth Factor-1 and CD98 J. Biol. Chem., April 16, 1999; 274(16): 11408 - 11416. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bleuel, S. Popp, N. E. Fusenig, E. J. Stanbridge, and P. Boukamp Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization PNAS, March 2, 1999; 96(5): 2065 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fontanini, L. Boldrini, A. Calcinai, S. Chine, M. Lucchi, A. Mussi, C. A. Angeletti, F. Basolo, and G. Bevilacqua Thrombospondins I and II Messenger RNA Expression in Lung Carcinoma: Relationship with p53 Alterations, Angiogenic Growth Factors, and Vascular Density Clin. Cancer Res., January 1, 1999; 5(1): 155 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Narimatsu, Y. Nagayama, K. Akino, M. Yasuda, T. Yamamoto, T.-t. Yang, A. Ohtsuru, H. Namba, S. Yamashita, H. Ayabe, et al. Therapeutic Usefulness of Wild-Type p53 Gene Introduction in a p53-Null Anaplastic Thyroid Carcinoma Cell Line J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3668 - 3672. [Abstract] [Full Text] |
||||
![]() |
K. Kuno and K. Matsushima ADAMTS-1 Protein Anchors at the Extracellular Matrix through the Thrombospondin Type I Motifs and Its Spacing Region J. Biol. Chem., May 29, 1998; 273(22): 13912 - 13917. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Kyriakides, Y.-H. Zhu, L. T. Smith, S. D. Bain, Z. Yang, M. T. Lin, K. G. Danielson, R. V. Iozzo, M. LaMarca, C. E. McKinney, et al. Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis J. Cell Biol., January 26, 1998; 140(2): 419 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hofsteenge, K. G. Huwiler, B. Macek, D. Hess, J. Lawler, D. F. Mosher, and J. Peter-Katalinic C-Mannosylation and O-Fucosylation of the Thrombospondin Type 1 Module J. Biol. Chem., February 23, 2001; 276(9): 6485 - 6498. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Rodrigues, N.-h. Guo, L. Zhou, J. M. Sipes, S. B. Williams, N. S. Templeton, H. R. Gralnick, and D. D. Roberts Conformational Regulation of the Fibronectin Binding and alpha 3beta 1 Integrin-mediated Adhesive Activities of Thrombospondin-1 J. Biol. Chem., July 20, 2001; 276(30): 27913 - 27922. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. J. Calzada, J. M. Sipes, J. A. Cashel, H. C. Krutzsch, D. S. Annis, D. F. Mosher, and D. D. Roberts Interactions of thrombospondins with {alpha}4{beta}1 integrin and CD47 differentially modulate T cell behavior J. Cell Biol., April 29, 2002; 157(3): 509 - 519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |